APOPTOSIS OF ENDOTHELIAL CELLS is evident in early stages of atherosclerosis and myocardial ischemia (16) . Strategies that limit apoptosis reduce vascular and myocardial damage. Therefore, it is important to identify the expression and regulation of pathways leading to apoptosis. Generally, apoptosis is believed to be a result of activation of caspases. Apoptosis-inducing factor (AIF) is a recently characterized proapoptotic mitochondrial protein (22) . It is normally confined to the mitochondrial intermembrane space, and upon release it translocates to the nucleus and stimulates chromatin condensation and 50-kb DNA fragmentation (21) . Microinjection of AIF into the cytoplasm of intact cells induces condensation of chromatin, dissipation of the mitochondrial transmembrane potential, and exposure of phosphatidylserine in the plasma membrane. None of these effects are prevented by a wide range of caspase inhibitors (9) . A pathological role for this protein has been described in non-small cell lung carcinoma (8) , somite cells exposed to ablation of axial structures (19) , injured brain cells (1, 2) , smooth muscle cell apoptosis (6) , neural tumor cells (20) , leukemia (24) , human immunodeficiency virus (5) , and renal ischemia (7) . AIF may be a complementary, cooperative, or redundant pathway along with caspase that leads to nuclear apoptosis.
In previous studies, we (13, 15) examined the biochemical mechanism of oxidized low-density lipoprotein (ox-LDL)-induced apoptosis of human coronary artery endothelial cells (HCAECs). We found that ox-LDL induces expression and activity of a lectin-like receptor for ox-LDL, LOX-1, which leads to apoptosis (13) . We (25) have recently demonstrated that ox-LDL also upregulates AIF expression in HCAECs in a concentration-and time-dependent manner. In the present study, we employed two different approaches, antisense phosphorothioate oligonucleotides (ODNs) directed at AIF mRNA and AIF overexpression, to determine the role of AIF in apoptosis of HCAECs.
METHODS

Materials.
Goat anti-human AIF polyclonal antiserum was obtained from Santa Cruz Biotechnology (San Diego, CA). Horseradish peroxidase (HRP)-labeled rabbit polyclonal antibody against goat IgG and HRP-labeled monoclonal antibodies against mouse IgG were from Calbiochem (La Jolla, CA). FITC-conjugated anti-goat IgG antibody, propidium iodide, and all other reagents, unless otherwise indicated, were from Sigma (St. Louis, MO).
Cell culture. An original batch of HCAECs was purchased from Clonetics (East Rutherford, NJ). The cells were cultured in endothelial basal medium-2 (Clonetics), which consisted of 500 ml endothelial cell basal medium, 5 ng human recombinant epidermal growth factor, 0.5 mg hydrocortisone, 25 mg gentamycin, 50 g amphotericin B, 6 mg bovine brain extract, and 25 ml FBS, as described previously (12, 13, 15, 25) . Fourth-generation HCAECs were used in this study. HCAECs were incubated with ox-LDL (10-40 g protein/ml) for 24 h, and the expression of AIF was determined. Parallel groups of HCAECs were pretreated with the caspase inhibitor ZVAD-fmk (50 M) for 30 min before the addition of ox-LDL for 24 h. Other groups of cells were treated with antisense ODNs to AIF (AIF-AS) or sense ODNs (AIF-S) (1 M) for 24 h, and HCAECs were then exposed to ox-LDL (40 g protein/ml) for 24 h to study the expression of AIF and induction of cell injury. Concentrations of all reagents were based on previous studies (12, 13, 25) . Parallel groups of cells were treated with pcDNA-AIF.
Preparation of ox-LDL. LDL was prepared as described previously (12, 13, 15, 25) . LDL was oxidized at 37°C in the presence of 5 mol/l CuSO 4 for up to 24 h and then dialyzed against three changes of PBS for 24 h. Ox-LDL samples were filter sterilized and incorporated in the culture medium. The integrity of the lipoproteins was confirmed by agarose gel electrophoresis.
AIF cloning of AIF cDNAs and transfection of HCAECs. AIF cDNAs were cloned by a combination of RT-PCR and rapid sequenc-ing, using primers specific for the 5Ј-and 3Ј-untranslated regions of the human AIF sequence. To generate the vector pcDNA-AIF, pcDNA3.1ϩ (Invitrogen) was cut with EcoRI/XhoI and ligated. PCRbased, site-directed mutagenesis of the AIF cDNA was followed by verification of the entire AIF cDNA sequence. pcDNA3.1 and pcDNA-AIF were purified using Qiagen Plasmid Kits.
The protein-coding region of AIF cDNA was inserted into the expression vector pcDNA (termed pcDNA-AIF). Vector alone (pcDNA) was used as a negative control. HCAECs were transfected with pcDNA plasmid alone or with pcDNA-AIF with the use of 3 l/ml SuperFect (Qiagen) and mixed with 5 g/ml plasmid for 48 h. The day before transfection, 10 6 cells were placed in a 100-mm dish in 10 ml endothelial culture medium. The cell number seeded produced ϳ80% confluence on the day of transfection. On the day of transfection, 10 g DNA dissolved in Tris-EDTA buffer and 60 l SuperFect Transfection Reagent was added to the DNA solution, and the transfection complex was formed as per the manufacturer's instructions. The cells were washed with PBS and then added to the tube containing the transfection complexes. Cells were allowed to incubate with the transfection complexes for 2-3 h. Thereafter, the medium was removed, and cells were washed with PBS. The cells were assayed for expression of the transfected gene. HCAECs were transfected with pcDNA-AIF or pcDNA for 48 h.
AIF-AS design. Antisense phosphorothioate ODNs and sense phosphorothioate ODNs (as controls) directed to the 5Ј-coding sequence of human AIF mRNA were developed as 23-mers targeted to the 5Ј-TCG CCG AAA TGT TCC GGT GTG GA-3Ј portion of the AIF sequence in collaboration with Integrated DNA Technologies. The corresponding control (sense) was also 23-mer.
Western blots. HCAECs were homogenized in ice-cold buffer [10 mM Tris⅐HCl (pH 7.9), 10 mM MgCl 2, and 0.5 mM PMSF]. The homogenate was centrifuged at 2,000 g for 10 min. Twenty micrograms of supernatant protein were loaded on a 10% SDS-PAGE and blotted on nitrocellulose filters. Immunoblots were performed with goat antibody against human AIF (Santa Cruz Biotechnology). Details of the methods are provided elsewhere (12, 25) .
Immunocytochemistry. Immunocytochemistry was used to identify translocation of AIF from mitochondria to the nucleus during apoptosis, as described previously (25) . Briefly, the cells were fixed on slides in cool methanol for 10 min at Ϫ20°C. The specimen was washed twice with PBS, blocked with 3% BSA in PBS for 15 min, and then covered with anti-AIF polyclonal antibody (1:20 dilution) in 3% BSA in PBS for 2 h at room temperature. After a wash, FITCconjugated secondary antibody (1:40 dilution) was applied for 1 h. Cells without anti-AIF antibody served as controls. After several washes, the slides were visualized under fluorescent microscopy.
Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling staining. Cultured cells were pretreated with AIF-AS or AIF-S (1 M) for 24 h and then exposed to ox-LDL (40 g protein/ml) for 24 h. The cells were then examined for apoptosis by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay (Promega). The method for TUNEL staining has been described previously (15, 17) .
Pulse-field gel electrophoresis. HCAECs were pretreated with AIF-AS or AIF-S before incubation with ox-LDL as described in Immunocytochemistry. To avoid nonspecific DNA breaks caused by phenol-chloroform extraction, chromosomal DNA samples were prepared in agarose plugs (18) using a CHEF mammalian genomic DNA plug kit (Bio-Rad). Cells (2.5 ϫ 10 5 ) were resuspended in 50 l of PBS, mixed with 50 l of preheated (50°C) 2% CleanCut agarose, and transferred into agarose plug molds. After solidification at room temperature, the plugs were incubated in 1 mg/ml proteinase-K overnight at 50°C. Deproteinized DNA-containing agarose plugs were washed in buffer. Pulse-field gel electrophoresis (PFGE) was performed on a CHEF-DR III pulsed-field electrophoresis system (BioRad). Fragments were separated on a 1% pulse-field agarose gel at 14°C for 20 h in 0.5ϫ Tris-borate-EDTA. Field strengths were 6 V/cm; initial and final switching time were set at 5-60 s with a 120°a ngle ramp. The gel was stained with ethidium bromide and visualized under ultraviolet light. DNA size standards (48.5-1,000 kb) were from Bio-Rad.
Caspase activity assay. Caspase activity was assessed by a colorimetric system (Oncogene). After pretreatment with AIF-AS or AIF-S (1 M) for 24 h, the cells were exposed to ox-LDL (40 g/ml) for Statistical analysis. All data are means Ϯ SD of at least three independent experiments and were subjected to ANOVA. A difference of P Ͻ 0.05 was considered to be statistically significant.
RESULTS
Effect of AS-AIF. HCAECs treated with ox-LDL (40 g/ml)
for 24 h showed an increase in AIF protein expression (3-to 4-fold compared with control; Fig. 1 ). The caspase inhibitor ZVAD-fmk did not inhibit this effect, as reported recently (25) .
In preliminary studies, we determined the inhibition of ox-LDL-mediated AIF protein expression by AIF-AS (0.2-2 M, incubation time 4-48 h) by HCAECs. We found that a 0.2 M concentration caused only minimal inhibition and 2 M concentration caused cell death. Maximal inhibition of AIF protein expression occurred with 1 M AIF-AS with an incubation time of 24 h. The 1 M concentration of AIF-AS and 24-h incubation time were used for subsequent studies. Others (13) have also observed similar concentration of AS and incubation time (ϳ24 h) as optimal. It is noteworthy that there was no significant difference in AIF expression when cells were treated with ox-LDL alone or with AIF-S plus ox-LDL. Figure 1 shows representative examples and summary data from three independent experiments.
Antisense and apoptosis. The number of TUNEL-positive cells increased markedly upon treatment of cells with ox-LDL for 24 h (P Ͻ 0.05), in accordance with our previous observations (12, 13, 25) . Pretreatment of cells with AIF-AS decreased apoptosis of HCAECs (P Ͻ 0.05), whereas pretreatment with AIF-S had no such effect (Fig. 2) . Antisense and AIF translocation. The immunolocation of AIF protein (green fluorescence) was restricted to out of the nucleus in quiescent cells. After treatment of HCAECs with ox-LDL, AIF protein translocated to the nuclei. Pretreatment with AIF-AS reduced this translocation, whereas AIF-S had no such effect (Fig. 2) .
Antisense and large DNA fragmentation. We employed PFGE to examine large DNA fragmentation in HCAECs treated with ox-LDL. PFGE showed that large DNA fragmentation was enhanced by treatment of cells with ox-LDL. Pretreatment of endothelial cells with AIF-AS markedly decreased DNA fragmentation. No significant alterations in DNA fragmentation was observed when cells were pretreated with AIF-S and then treated with ox-LDL or left untreated before exposure to ox-LDL (Fig. 3) .
Antisense and caspase-3 activity. We examined whether the ox-LDL-mediated upregulation of caspase-3 activity was affected by the expression of AIF. In cells treated with ox-LDL alone, there was a marked increase in caspase-3 activity (P Ͻ 0.01 vs. control); however, pretreatment with AIF-AS or AIF-S had no significant effect on caspase-3 activity. Note that pretreatment of cells with the caspase inhibitor significantly decreased caspase-3 activity (Fig. 4) .
Recombinant plasmid pcDNA-AIF and apoptosis. As shown in Figs. 5 and 6, transfection of HCAECs with pcDNA-AIF resulted in a marked increase in AIF protein, apoptosis (TUNEL assay), and translocation of AIF from the cytoplasm to the nucleus.
DISCUSSION
The present study confirms previous results (25) showing that AIF is present in HCAECs. To establish the pathophysiological significance of AIF in injury to HCAECs, we used antisense phosphorothioated ODNs directed at AIF mRNA that selectively interfered with the expression of AIF in response to ox-LDL. We examined the modulation of ox-LDL-mediated injury (apoptosis) by TUNEL as well as by PFGE and confirmed the occurrence of apoptosis when HCAECs were treated with ox-LDL. Importantly, pretreatment of cells with AIF-AS, but not AIF-S, decreased ox-LDL-mediated apoptosis. AIF-AS pretreatment also reduced AIF translocation without affecting caspase-3 activity. In other experiments, we showed that pcDNA-AIF into HCAECs induced apoptosis and translocation of AIF from the cytoplasm into the nucleus. Accordingly, we believe that AIF expression is an important caspase-independent event leading to chromatin condensation and DNA degradation when HCAECs are exposed to ox-LDL.
We observed large-molecular-weight DNA fragmentation when HCAECs were treated with ox-LDL. The large-molecular-weight fragmentation is thought to be characteristic of apoptosis (21) . Notably, the pretreatment of cells with the AIF-AS inhibited formation of large DNA fragments. These observations provide strong evidence that ox-LDL induces apoptosis in HCAECs mediated at least in part by expression of AIF.
It is of note that AIF-AS did not affect the activity of caspase-3, which suggests that the effect of AIF-AS was independent of caspase activity. This concept also gains support from the observation that the caspase inhibitor ZVAD-fmk did not affect increased expression of AIF when the cells were treated with ox-LDL, but reduced caspase-3 activity.
We have previously shown an important role of the caspasedependent pathway in ox-LDL-mediated apoptosis of HCAECs (18) . We found that the inhibition of caspase-3 could not completely block ox-LDL-induced apoptosis. The present study suggests that expression and activation of AIF could be a caspase-independent pathway that is responsible for part of the ox-LDL-mediated apoptosis in endothelial cells. In other preliminary studies (data not shown), we examined the effect of the combination of AIF-AS and ZVAD-fmk on ox-LDLmediated apoptosis and observed that while the combination had more potent effect than either agent alone, there was still significant amount of apoptosis. These data collectively suggest the presence of pathways of apoptosis beyond caspase and AIF.
In other studies, we used pcDNA-AIF and observed that transfection of cells with pcDNA-AIF resulted in an upregulation of AIF expression and a simultaneous increase in apoptosis. These data complement the result from AIF-AS experiments and demonstrate the pathological significance of AIF in HCAECs.
Vascular endothelium becomes activated in the early stages of atherosclerosis (10) and allows attachment of inflammatory cells (17) . Programmed cell death or apoptosis is a critical feature of endothelium and other cells, such as monocytes, in the atherosclerotic lesions (11, 16) . Apoptosis is also seen in ischemic-reperfused myocardium (14) . It is of note that ox-LDL accumulates in significant amount in, as well as around, the ischemic-reperfused regions (4) . Significantly, it is important to define different pathways leading to cell injury.
In summary, we have demonstrated by two different approaches, i.e., use of antisense ODNs directed at AIF mRNA to inhibit AIF expression and the use of pcDNA-AIF to upregulate AIF expression, that AIF is a pathological mechanism in the induction of apoptosis in HCAECs. AIF pathway does not negate the importance of the caspases and other pathways of apoptosis in HCAECs.
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